Goserelin Acetate Patent Expiration
Goserelin Acetate was first introduced by Tersera Therapeutics Llc
Goserelin Acetate Patents
Given below is the list of patents protecting Goserelin Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zoladex | US7118552 | Automatically operable safety shield system for syringes |
Apr 13, 2022
(Expired) | Tersera |
| Zoladex | US7220247 | Automatically operable safety shield system for syringes |
Apr 09, 2022
(Expired) | Tersera |
| Zoladex | US7500964 | Automatically operable safety shield system for syringes |
Feb 26, 2021
(Expired) | Tersera |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Goserelin Acetate's patents.
Latest Legal Activities on Goserelin Acetate's Patents
Given below is the list recent legal activities going on the following patents of Goserelin Acetate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Aug, 2020 | US7500964 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Oct, 2018 | US7220247 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Mar, 2018 | US7118552 |
| Email Notification Critical | 07 Jun, 2017 | US7500964 |
| Change in Power of Attorney (May Include Associate POA) Critical | 07 Jun, 2017 | US7500964 |
| Correspondence Address Change Critical | 05 Jun, 2017 | US7500964 |
| Electronic Review Critical | 30 May, 2017 | US7500964 |
| Email Notification Critical | 26 May, 2017 | US7500964 |
| Mail Pre-Exam Notice | 26 May, 2017 | US7500964 |
| Change in Power of Attorney (May Include Associate POA) Critical | 24 May, 2017 | US7118552 |
Goserelin Acetate's Family Patents
